Tradestie Institutional Equity Comparison Engine
VVOS vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus DCTH at 69.0x Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in CONSOLIDATION (26th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
VVOS N/M vs DCTH 69.0x Fwd P/E
Growth & Margin Winner
DCTH
Op Margin -107.9% vs 5.2% ยท YoY +34.9% vs +70.7%
Momentum & Technical Winner
DCTH
1Y -97.7% vs +120.8% ยท 52W Pos 0% vs 74%
Options & Structure Winner
DCTH
BREAKDOWN (N/A IV) vs CONSOLIDATION (26th %ile IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$18.79
-2.34% 1D
Market Cap
$669.3M
1M Return
+27.39%
1Y Return
+120.8%
Forward P/E
69.0x
Unified AI Score
35.2 / 100
SELL
Tech 50.0
Fund 36.0
Flow 70.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
DCTH +120.8%
Spread: +218.51 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VVOS Revenue | DCTH Revenue | VVOS Op. Margin | DCTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2015 | N/A | $0M | N/A | -870.6% | DCTH |
| FY2019 | $10M | N/A | -92.8% | N/A | VVOS |
| FY2020 | $10M | N/A | -92.1% | N/A | VVOS |
| FY2021 | $20M | $0M | -120.7% | -690.0% | VVOS |
| FY2022 | $20M | $0M | -156.2% | -1245.1% | VVOS |
| FY2023 | $10M | $0M | -125.3% | -1849.0% | VVOS |
| FY2024 | $20M | $40M | -74.3% | -33.4% | DCTH |
| FY2025 | $20M | $90M | -114.1% | 0.8% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | $669.3M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | N/M | 120.2x | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | 69.0x | Lower Multiple | DCTH |
| Revenue Growth (YoY) Growth | +34.9% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -107.9% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -121.8% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 74% ($8โ$23) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 1.57ฮฒ ยท 130% Vol | Lower Realized Risk | VVOS |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 35.2 / 100 (SELL) | Higher Composite | VVOS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs DCTH Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DCTH
CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
26th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.